AURO-FLUOXETINE 10 MG
FLUOXETINE (FLUOXETINE HYDROCHLORIDE) : 10 MG · DIN 02385627 · AURO PHARMA INC
Health Canada status: MARKETED
What is AURO-FLUOXETINE?
AURO-FLUOXETINE 10 MG contains FLUOXETINE (FLUOXETINE HYDROCHLORIDE) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02385627, held by AURO PHARMA INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 24-Jul-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AURO-FLUOXETINE used for?
Auro-Fluoxetine is indicated in adults for: Depression (symptomatic relief of Major Depressive Disorder (MDD)), Bulimia Nervosa (significantly decrease binge-eating and purging activity), and Obsessive-Compulsive Disorder (OCD) (symptomatic treatment of obsessive-compulsive disorder (OCD)).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02385627 |
|---|---|
| Brand name | AURO-FLUOXETINE |
| Generic / active ingredient | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) : 10 MG |
| Manufacturer | AURO PHARMA INC |
| Strength | 10 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AB03 FLUOXETINE |
| AHFS class | 28:08.92 ; 04:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Jul-2012 |
| Original market date | 2012-10-02 00:00:00 |
How is it stored and handled?
null
How is it supplied?
HDPE bottles of 100’s, 250’s and 1000’s and blister pack of pack size of 10X10’s count for 10mg. HDPE bottles of 100’s, 250’s, 500’s and 1000’s and blister pack of pack size of 10X10’s count for 20mg.
Is FLUOXETINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N06AB03 FLUOXETINE. 35 of 94 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-FLUOXETINE | 10 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02393441 |
| ACH-FLUOXETINE | 20 MG | CAPSULE | ACCORD HEALTHCARE INC | MARKETED | DIN 02383241 |
| APO-FLUOXETINE | 10 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02216353 |
| APO-FLUOXETINE | 20 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02216361 |
| APO-FLUOXETINE | 20 MG / 5 ML | SOLUTION | APOTEX INC | MARKETED | DIN 02231328 |
| AURO-FLUOXETINE | 20 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02385635 |
| BIO-FLUOXETINE | 10 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02448424 |
| BIO-FLUOXETINE | 20 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02448432 |
| FLUOXETINE | 10 MG | CAPSULE | SANIS HEALTH INC | MARKETED | DIN 02286068 |
| FLUOXETINE | 10 MG | CAPSULE | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02374447 |
Who else supplies FLUOXETINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUOXETINE appears in 900 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.